InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by McMinn Rachel, Chief Executive Officer. Officer active across 1 companies, notably Neurogene Inc.. In total, 2 reports have been logged. The latest transaction was filed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
025,900 shares0
Common Stock
SEC:0001606302-26-000002·
025,900 shares0
Common Stock
SEC:0001606302-26-000002:0·
2 of 2 declarations
About McMinn Rachel
Rachel McMinn is the Chief Executive Officer of Neurogene Inc. She leads the company, focusing on growth strategy and innovation. Her leadership is crucial for achieving organizational goals and strengthening the market position of the firm.
